Last quarter (Q4 2022), Amplia Therapeutics Ltd.'s total revenue was AU$―, a decrease of ― from the same quarter last year. In Q4, Amplia Therapeutics Ltd.'s net income was AU$―. See Amplia Therapeutics Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
Total Revenue	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	-	AU$ 5.63M	AU$ 3.87M	AU$ 2.26M	AU$ 1.94M	AU$ 4.97M
Operating Income	-	AU$ -5.63M	AU$ -3.87M	AU$ -2.26M	AU$ -1.94M	AU$ -4.97M
Net Non Operating Interest Income Expense	-	AU$ -534.00	AU$ 1.29K	AU$ 3.72K	AU$ 20.28K	AU$ 26.97K
Other Income Expense	-	AU$ 1.98M	AU$ 1.59M	AU$ 34.23K	AU$ 50.47K	AU$ 642.84K
Pretax Income	-	AU$ -3.64M	AU$ -2.28M	AU$ -2.22M	AU$ -1.87M	AU$ -4.30M
Tax Provision	-	AU$ 0.00	AU$ 0.00	AU$ 0.00	AU$ 0.00	AU$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	-	AU$ -3.64M	AU$ -2.28M	AU$ -2.22M	AU$ -1.87M	AU$ -4.30M
Basic EPS	-	AU$ -0.03	AU$ -0.02	AU$ -0.04	AU$ -0.04	AU$ -0.19
Diluted EPS	-	AU$ -0.03	AU$ -0.02	AU$ -0.04	AU$ -0.04	AU$ -0.19
Basic Average Shares	-	AU$ 145.55M	AU$ 95.70M	AU$ 52.96M	AU$ 42.98M	AU$ 22.56M
Diluted Average Shares	-	AU$ 145.55M	AU$ 95.70M	AU$ 52.96M	AU$ 42.98M	AU$ 22.56M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	-	-	-	-	-	-
Net Income From Continuing And Discontinued Operation	-	AU$ -3.64M	AU$ -2.28M	AU$ -2.22M	AU$ -1.87M	AU$ -4.30M
Normalized Income	-	AU$ -3.64M	AU$ -2.28M	AU$ -2.22M	AU$ -1.87M	AU$ -4.30M
Interest Expense	-	AU$ 1.15K	-	-	-	-
EBIT	-	AU$ -3.64M	AU$ -3.87M	AU$ -2.26M	AU$ -1.94M	AU$ -4.97M
EBITDA	-	AU$ -3.64M	AU$ -3.87M	AU$ -2.26M	AU$ -1.94M	AU$ -4.95M

Currency in AUD

Amplia Therapeutics Ltd. Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing